November 12, 2013
Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
September 14, 2013
Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
July 5, 2013
BioMarin is seeking Vimizim approval in Brazil.
December 10, 2012
On a good day for the market, the Nasdaq is trading up 0.6%, the S&P 500 is up 0.2% and the Dow has increased 0.3%. The healthcare ...
September 10, 2012
The Nasdaq has slipped 0.6%, the S&P 500 is unchanged and the Dow is trading up 0.1% after the morning's trading. The healthcare ...
August 20, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 is down 0.3%; and the Dow is trading down ...
August 17, 2011
In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
July 2, 2010
If biotech companies are buying each other, should investors get in on the action?
April 15, 2009
Despite positive Phase 3 results, this medicine-maker's valuation is excessive and its new drug won't make it to market for ...
June 20, 2008
Stocks that can string together many quarters of positive earnings surprises are usually rewarded. Learn why the market loves ...